Shizuoka, Japan

Kazuhiko Nakano

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 21.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuhiko Nakano: Innovator in Peptide-Compound Cyclization

Introduction

Kazuhiko Nakano is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of drug discovery through his innovative methods for cyclizing peptide compounds. With a total of 3 patents to his name, Nakano is recognized for his dedication to advancing pharmaceutical research.

Latest Patents

One of Nakano's latest patents is a peptide-compound cyclization method. The objective of this invention is to provide methods for discovering drugs that are effective for tough targets, which have traditionally been challenging to identify. This invention relates to novel methods for cyclizing peptide compounds, as well as novel peptide compounds and libraries that comprise these compounds, aimed at achieving the aforementioned objective.

Career Highlights

Kazuhiko Nakano is currently associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company. His work focuses on developing innovative solutions that enhance drug discovery processes. His expertise in peptide chemistry has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Nakano has collaborated with talented individuals such as Shiori Kariyuki and Takeo Iida. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Kazuhiko Nakano's contributions to peptide-compound cyclization represent a significant advancement in drug discovery. His innovative methods and collaborations continue to influence the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…